Cargando…
Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer
As gene transfer with adeno-associated virus (AAV) vectors is starting to enter clinical practice, this review examines the impact of vector capsid choice in liver-directed gene transfer for hemophilia. Given that there are multiple clinical trials completed and ongoing in this field, it is importan...
Autores principales: | Pipe, Steven, Leebeek, Frank W.G., Ferreira, Valerie, Sawyer, Eileen K., Pasi, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807344/ https://www.ncbi.nlm.nih.gov/pubmed/31660419 http://dx.doi.org/10.1016/j.omtm.2019.08.015 |
Ejemplares similares
-
Tailoring the AAV2 capsid vector for bone-targeting
por: Alméciga-Díaz, Carlos J., et al.
Publicado: (2018) -
Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019) -
Ancestral library identifies conserved reprogrammable liver motif on AAV capsid
por: Zinn, Eric, et al.
Publicado: (2022) -
Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016) -
Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
por: Markusic, David M., et al.
Publicado: (2017)